News and events from NCI-funded research and programs
News & Events
Recent News Releases
NCI study outlines opportunities to achieve President Biden’s Cancer Moonshot goal of reducing cancer death rates in the United States
A new study has outlined opportunities for achieving President Biden and First Lady Biden’s Cancer Moonshot goal of reducing the cancer death rate by at least 50% over the next 25 years.
Pragmatica-Lung Study, a streamlined model for future cancer clinical trials, begins enrolling patients
NCI has helped launch the Pragmatica-Lung Study, a phase 3 randomized clinical trial of a two-drug combination to treat patients with advanced non-small cell lung cancer. The simplified trial design aims to increase accessibility for participants.
NCI study finds that immunotherapy substantially increases survival of people with lymphomatoid granulomatosis
An NCI study shows that people with low-grade lymphomatoid granulomatosis who are treated with interferon alfa-2b, a type of immunotherapy, can live for decades after diagnosis.
Cancer Grand Challenges announces global research funding opportunity with nine new challenges
As part of the Cancer Grand Challenges program, NCI and Cancer Research UK have announced nine new research challenges to tackle profound problems in cancer research.
NCI clinical trial leads to atezolizumab approval for advanced alveolar soft part sarcoma
A clinical trial led by NCI has resulted in FDA approval of the immunotherapy drug atezolizumab (Tecentriq) to treat advanced alveolar soft part sarcoma.
Statement from Monica M. Bertagnolli, M.D., Director, National Cancer Institute, National Institutes of Health
A statement from the National Cancer Institute by NCI Director Monica M. Bertagnolli, M.D., about her recent diagnosis with early breast cancer.
Annual Report to the Nation: Cancer deaths continue downward trend; modest improvements in survival for pancreatic cancer
Overall cancer death rates continued to fall among men, women, children, and adolescents and young adults in every major racial and ethnic group in the United States from 2015 to 2019, according to the latest Annual Report to the Nation on the Status of Cancer.
Monica Bertagnolli begins work as 16th director of the National Cancer Institute
Monica M. Bertagnolli, M.D., begins her tenure as the 16th director of the National Cancer Institute on October 3, 2022. She previously served as the Richard E. Wilson Professor of Surgery in the field of surgical oncology at Harvard Medical School, a surgeon at Brigham and Women’s Hospital, and a member of the Gastrointestinal Cancer Treatment and Sarcoma Centers at Dana-Farber Cancer Institute.
A healthy lifestyle may help former smokers lower their risk of death from all causes
A new study finds that former smokers who stick to a healthy lifestyle have a lower risk of dying from all causes, including cancer and heart and lung disease, than those who don’t have healthy habits.
NCI study of tea drinkers in the UK suggests health benefits from black tea
A prospective study of half a million tea drinkers in the U.K. suggests potential mortality benefits of drinking black tea may be associated with a lower risk of death.